Rajen J Mody MB BS
Hematologist (Pediatric) | Pediatric Hematology-Oncology
1500 East Medical Cneter Dr 7th Floor Cs Mott Ch Ann Arbor MI, 48109About
Dr. Rajen Mody joined the Division of Pediatric Hematology/Oncology following completion of his fellowship training in pediatric hematology/oncology at the University of Michigan. He subsequently comp ...
Education and Training
Smt. N.H.L. Municipal Medical College MBBS
Board Certification
DermatologyAmerican Board of DermatologyABD
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation.
- Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.
- Ethanol locks therapy for resolution of fungal catheter infections.
- Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.
Clinical Trials
- Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
- Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
- Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
- Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
- WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
- WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
- Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
- Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
- Selumetinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
- Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
- Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
- Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Professional Memberships
- Member American Society of Pediatric Hemtology-Oncology
- Member American Association of Cancer Research
- Member Children's Oncology Group
- Member American Society of Hematology
Fellowships
- Pediatric Oncology, Gujarat Cancer & Research Institute MP Shah Cancer Hospital 1994
- Pediatric Hematology/Oncology, University of Michigan Medical Center 2000
Rajen J Mody MB BS's Practice location
Rajen Mody
1500 East Medical Cneter Dr 7th Floor Cs Mott Ch -Ann Arbor, MI 48109Get Direction
Rajen J Mody MB BS's reviews
Write ReviewRecommended Articles
![]()
What Does Vicodin Do, and How Long Does Vicodin Stay in Your System?Vicodin is a blended drug used for pain management, comprising two ingredients: acetaminophen and hydrocodone. The effects of Vicodin last for about four hours, however, traces of the drug will remain in the body for several days and can even be present in the hair for the next few months.The...
![]()
Chlamydia in WomenWhat Is Chlamydia?Chlamydia is considered to be the most common sexually transmitted disease in the U.S. The disease is more commonly found in women than in men. It is an infection mainly caused by the bacteria known as Chlamydia trachomatis. Chlamydia is similar to gonorrhea, having a similar...
![]()
Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant RecipientsLymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
![]()
PurpuraPurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
![]()
Potential Causes of LeukopeniaIntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
![]()
How Is Leukemia Diagnosed?Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
Nearby Providers
![]()
Dr. Valerie P Opipari MD1500 East Medical Center Dr Ann Arbor MI 48109![]()
Dr. Aghiad Chamdin MD1500 East Medical Center Dr Ann Arbor MI 48109![]()
Dr. Jordan A Shavit MD1500 East Medical Center Dr Ann Arbor MI 48109![]()
Dr. Andrew D Campbell MD1500 E Medical Center Dr Ann Arbor MI 48109![]()
Dr. Andrew C Harris M.D.1500 E Medical Center Drive Ann Arbor MI 48109![]()
Dr. Steven W Pipe MD1500 E Medical Center Dr Ann Arbor MI 48109
Nearest Hospitals
ST JOSEPH MERCY HOSPITALl
5301 E HURON RIVER DR ANN ARBOR MI 48106ST JOSEPH MERCY CHELSEAl
775 S MAIN ST CHELSEA MI 48118